Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simona Mercogliano
Observed names:
Mercogliano, Simona,
S. Mercogliano
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
ORCID:
0009-0000-3089-6141
Observed ORCID:
0009-0000-3089-6141
OpenAlex ID:
A5093214610
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial
2023
·
Valentina Borzillo
, Esmeralda Scipilliti
, et al.
·
Frontiers in Oncology
·
8
PDF
Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges
2026
·
R. Di Franco
, R. Mottareale
, et al.
·
Radiation Oncology
·
7
Optimizing Left-Sided Breast Cancer Radiotherapy: Strategy-Dependent Trade-Offs Among VMAT and Hybrid Techniques
2026
·
Rocco Mottareale
, Francesca Buonanno
, et al.
·
Cancer Management and Research
·
1
PDF
Dosiomics-based prediction of late genitourinary side-effects after CyberKnife for prostate cancer: a SHAP-explainable machine learning approach
2026
·
Rocco Mottareale
, Marcello Serra
, et al.
·
BMC Cancer
Explainable machine learning predictive models for treatment response after SBRT in melanoma brain metastases
2026
·
Savino Cilla
, Rossella Di Franco
, et al.
·
Journal of Neuro-Oncology
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial
2026
·
Rossella Di Franco
, Simona Mercogliano
, et al.
·
Figshare
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial
2026
·
Rossella Di Franco
, Simona Mercogliano
, et al.
·
Future Oncology
PDF
Breast cancer radiotherapy in patients with autoimmune or cancer-associated myositis: balancing oncological benefit and immune-mediated risk
2026
·
Sara Falivene
, Simona Mercogliano
, et al.
·
Radiation Oncology
PDF
First Results Comparing MLC Versus IRIS CyberKnife Collimators in Prostate Stereotactic Body Radiation Therapy in an Italian Oncology Institute
2026
·
Gaetano Gagliardo
, Marcello Serra
, et al.
·
Bioengineering
Corrigendum to “Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)” [Clin Oncol 52C (2026) 104084]
2026
·
R. Di Franco
, D. Pezzulla
, et al.
·
Clinical Oncology
3226 Explainable machine learning predictive model for treatment response after SBRT in melanoma brain metastases
2026
·
Savino cilla
, Donato Pezzulla
, et al.
·
Radiotherapy and Oncology
2151 Development and Preliminary Evaluation of a Dosiomic Classifier for Early PSA Decay Kinetics after CyberKnife SBRT in Prostate Cancer
2026
·
Rocco Mottareale
, Rossella Di Franco
, et al.
·
Radiotherapy and Oncology
1385 Safety and Efficacy of Spinal Re-Irradiation: Preliminary Results from the Multicentric RIMESPINE Trial
2026
·
Donato Pezzulla
, Liliana Belgioia
, et al.
·
Radiotherapy and Oncology
1899 Spatially Fractionated Radiotherapy (SFRT) for Bulky Tumors: A Systematic Review of Clinical Outcomes and Dosimetric Variability
2026
·
Rossella DI FRANCO
, Rocco Mottareale
, et al.
·
Radiotherapy and Oncology
3130 Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for Glioblastoma
2026
·
Miriam Torrisi
, Andrei Fodor
, et al.
·
Radiotherapy and Oncology
4244 Brain Radionecrosis Risk Due to Radiosurgery for Brain Metastases: Virtuose Trial, a Retrospective Multicentric Study of Brain Tumor Group of Airo
2026
·
Fiammetta Meacci
, Lucia Pia Ciccone
, et al.
·
Radiotherapy and Oncology
Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial
2026
·
Nadia Di Muzio
, Miriam Torrisi
, et al.
·
BMC Cancer
First results comparing MLC versus IRIS CyberKnife collimators in prostate Stereotactic Body Radiation Therapy in our Institute
2026
·
Gagliardo, Gaetano
, Serra, Marcello
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy
2026
·
R. Di Franco
, D. Pezzulla
, et al.
·
Clinical Oncology
PDF
A randomised clinical trial to improve healthy lifestyle adherence in prostate cancer patients undergoing radiotherapy (Microstyle study).
2025
·
Sara Gandini
, Giulia Marvaso
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
20
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type